Don't Just Read the News, Understand It.
Published loading...Updated

HHS cancels nearly $600 million Moderna contract on vaccines for flu pandemics

  • On Wednesday, May 28, 2025, the Trump administration withdrew $766 million in funding previously allocated to Moderna for the development of an mRNA-based bird flu vaccine in the United States.
  • This cancellation followed two funding awards to Moderna in January and July 2024 totaling $766 million aimed at supporting late-stage vaccine development and purchase.
  • Moderna reported encouraging interim data from a Phase 1/2 study of its mRNA-1018 vaccine, which targets the H5 avian influenza strain and was evaluated in approximately 300 healthy participants.
  • The HHS stated that further funding for Moderna’s H5N1 mRNA vaccine cannot be justified from a scientific or ethical standpoint, highlighting issues related to safety and trustworthiness.
  • The funding withdrawal creates uncertainty around bird flu pandemic preparedness, and Moderna stated it will explore alternative paths to advance the vaccine program.
Insights by Ground AI
Does this summary seem wrong?

340 Articles

All
Left
49
Center
165
Right
38
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 65% of the sources are Center
65% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

KGW 8 broke the news in Portland, United States on Wednesday, May 28, 2025.
Sources are mostly out of (0)